Asthma; Eosinophilic Clinical Trial
Official title:
The Influence of Inhaled CorticoSteroids Adherence on Treatment Response to Mepolizumab in Severe Eosinophilic Asthma (CSAREA Study)
The study aim is to look at the effect of the regular use of inhaled corticosteroids on the response and received from mepolizumab treatment which you are receiving or had received before.
Examine the outcomes of 250 patients who have been treated with mepolizumab within BRSAS and compare the adherence to ICS in the responders and non-responder groups. If confirmed that non-adherence to ICS was related to poor response to mepolizumab, steps then will be undertaken to better monitor and enhance adherence to ICS to improve patients outcomes and response to mepolizumab treatment. This study will rely on retrospective analysis of medically existing data within the service ,the adherence to ICS treatment will be measured using the prescription possession ratio "PPR" Data is available in the patients' GP records and forms part of the routine clinical practice of the severe asthma clinic to monitor adherence to ICS treatment. For a significant number of patients ,such data will be already available within patient medical records held at University Hospitals Birmingham NHS Foundation Trust (UHB), however missing data is expected and in such cases GP surgeries will be contacted to obtain the PPR. Patients will be asked to agree to access to GP records as part of the informed consent process. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04742504 -
Interaction Between Benralizumab and Basophils in Eosinophilic Asthma
|
||
| Recruiting |
NCT04565483 -
Predictive Signature of Benralizumab Response
|
Phase 4 | |
| Completed |
NCT04181190 -
Effects of Anti-IL5 Biological Treatments on Blood IgE Levels in Severe Asthmatic Patients
|
||
| Recruiting |
NCT05787678 -
Dupilumab Efficacy on Bronchial Inflammation, Small Airways Disfunction and Mucous Secretion
|
||
| Completed |
NCT04456270 -
Asthma Control in a Dutch Primary Care Population
|
||
| Not yet recruiting |
NCT05091385 -
Efficacy of Mepolizumab in Polish Patients With Severe Eosinophilic Asthma
|
||
| Recruiting |
NCT05078281 -
Patients With Severe Eosinophilic Asthma Treated With Benralizumab
|
||
| Recruiting |
NCT04512521 -
Functional Lung MRI for Early Treatment Response Assessment for Patients With Eosinophilic Asthma
|
||
| Recruiting |
NCT05813288 -
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)
|
Phase 3 | |
| Recruiting |
NCT04319705 -
Anti-viral Effects of Azithromycin in Patients With Asthma and COPD
|
Phase 4 | |
| Recruiting |
NCT06288516 -
BenRalizumab Effect on Airway Remodeling in Severe asTHma
|
Phase 4 | |
| Active, not recruiting |
NCT03733535 -
Evaluating the Effect of Benralizumab in Severe, Poorly-controlled Eosinophilic Asthma Using Inhaled Hyperpolarized 129-Xenon MRI
|
N/A | |
| Not yet recruiting |
NCT05404763 -
Mepolizumab and Physical Activity in Severe Asthma
|
||
| Not yet recruiting |
NCT04924478 -
Evaluation of Volatile Organic Compounds in Mepolizumab Therapy
|
||
| Recruiting |
NCT05763121 -
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.
|
Phase 3 | |
| Recruiting |
NCT05748600 -
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma
|
Phase 3 | |
| Completed |
NCT03453021 -
Effect of Mepolizumab on Decrease of Systemic Corticosteroids in Patients With Severe Eosinophilic Asthma
|
||
| Active, not recruiting |
NCT04612556 -
Efficacy of Mepolizumab in Severe Asthmatics on a Long Term (MESILICO)
|
||
| Completed |
NCT04710134 -
Efficacy of Reslizumab Dose Escalation in Patients With Severe Asthma
|
Phase 4 | |
| Not yet recruiting |
NCT05144087 -
The Influence of Mepolizumab on Structural and Inflammatory Cells in Severe Eosinophilic Asthma
|